Matthew L Sherman
CIK 1325710 · EVP & Chief Medical Officer · last filed 2024-06-11
Matthew L Sherman is an EVP & Chief Medical Officer who has filed 77 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for DCPH, was dated Jun 11, 2024. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.0K
5
77
-$7.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | EVP & Chief Medical Officer | 0 | $25.59 | $0 | -$445.2K | 21 | 2024-06-11 |
| PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Director | — | $13.60 | — | $0 | 7 | 2023-06-23 |
| LUMOS PHARMA, INC. (NLNK) Delisted | Director | — | — | — | $0 | 3 | 2019-08-02 |
| PULM | Director | 20,000 | $1.40 | $28.0K | $0 | 5 | 2019-05-20 |
| ACCELERON PHARMA INC (XLRN) Delisted | EVP & Chief Medical Officer | 77,267 | $178.75 | $13.81M | -$7.39M | 41 | 2018-04-04 |
Recent Filings
77 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-11 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | −110,133 | $0 | EDGAR |
| 2024-02-20 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +14,660 | -$40.8K | EDGAR |
| 2024-01-18 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −2,435 | -$35.2K | EDGAR |
| 2023-12-14 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +5,452 | -$42.9K | EDGAR |
| 2023-10-31 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +5,884 | -$28.4K | EDGAR |
| 2023-10-04 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −2,942 | -$37.3K | EDGAR |
| 2023-06-23 | PALVELLA THERAPEUTICS, INC. (PIRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-21 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −1,655 | -$23.8K | EDGAR |
| 2023-02-17 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +15,517 | -$14.7K | EDGAR |
| 2023-01-19 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Sell (S) | −2,403 | -$51.0K | EDGAR |